The post INJ Price Prediction: Technical Recovery to $6.33 Before December Correction to $5.17 appeared on BitcoinEthereumNews.com. Iris Coleman Nov 22, 2025 17:59 INJ price prediction shows recovery to $6.33 within one week, followed by potential decline to $5.17 by December 21. Mixed analyst forecasts reflect current market uncertainty. INJ Price Prediction Summary • INJ short-term target (1 week): $6.33 (+16.4%) • Injective medium-term forecast (1 month): $5.17-$7.50 range• Key level to break for bullish continuation: $6.74 (20-day SMA) • Critical support if bearish: $5.19 (immediate support) Recent Injective Price Predictions from Analysts The latest INJ price prediction landscape reveals a divided analyst community. Blockchain.News maintains an optimistic stance with their Injective forecast targeting $6.33 in the short term, despite the recent 12.88% decline. Their medium-term projection extends to $7.50-$9.17, banking on the upcoming Altria upgrade as a catalyst. However, contrarian views emerge from CoinCheckup’s technical analysis, which suggests a bearish INJ price target of $5.17 by December 21, 2025. This creates an interesting dichotomy where short-term optimism meets medium-term pessimism. CoinMarketCap’s $9.17 prediction relies heavily on the Altria Mainnet Upgrade and potential ETF approvals, while Coinbase’s conservative long-term forecast of $7.14 by 2030 reflects a modest 5% annual growth expectation. The consensus reveals medium confidence levels across most predictions, indicating uncertainty in the current market environment for Injective. INJ Technical Analysis: Setting Up for Short-Term Recovery Current technical indicators paint a mixed but potentially recovering picture for our INJ price prediction. With INJ trading at $5.44, the token sits precariously close to its 52-week low of $5.44, suggesting we may have found a temporary floor. The RSI reading of 31.18 indicates oversold conditions without reaching extreme levels, providing room for a technical bounce. The MACD histogram at -0.0621 shows bearish momentum is weakening, though not yet reversed. Most compelling is INJ’s position within the Bollinger Bands at 0.0347,… The post INJ Price Prediction: Technical Recovery to $6.33 Before December Correction to $5.17 appeared on BitcoinEthereumNews.com. Iris Coleman Nov 22, 2025 17:59 INJ price prediction shows recovery to $6.33 within one week, followed by potential decline to $5.17 by December 21. Mixed analyst forecasts reflect current market uncertainty. INJ Price Prediction Summary • INJ short-term target (1 week): $6.33 (+16.4%) • Injective medium-term forecast (1 month): $5.17-$7.50 range• Key level to break for bullish continuation: $6.74 (20-day SMA) • Critical support if bearish: $5.19 (immediate support) Recent Injective Price Predictions from Analysts The latest INJ price prediction landscape reveals a divided analyst community. Blockchain.News maintains an optimistic stance with their Injective forecast targeting $6.33 in the short term, despite the recent 12.88% decline. Their medium-term projection extends to $7.50-$9.17, banking on the upcoming Altria upgrade as a catalyst. However, contrarian views emerge from CoinCheckup’s technical analysis, which suggests a bearish INJ price target of $5.17 by December 21, 2025. This creates an interesting dichotomy where short-term optimism meets medium-term pessimism. CoinMarketCap’s $9.17 prediction relies heavily on the Altria Mainnet Upgrade and potential ETF approvals, while Coinbase’s conservative long-term forecast of $7.14 by 2030 reflects a modest 5% annual growth expectation. The consensus reveals medium confidence levels across most predictions, indicating uncertainty in the current market environment for Injective. INJ Technical Analysis: Setting Up for Short-Term Recovery Current technical indicators paint a mixed but potentially recovering picture for our INJ price prediction. With INJ trading at $5.44, the token sits precariously close to its 52-week low of $5.44, suggesting we may have found a temporary floor. The RSI reading of 31.18 indicates oversold conditions without reaching extreme levels, providing room for a technical bounce. The MACD histogram at -0.0621 shows bearish momentum is weakening, though not yet reversed. Most compelling is INJ’s position within the Bollinger Bands at 0.0347,…

INJ Price Prediction: Technical Recovery to $6.33 Before December Correction to $5.17

2025/11/23 10:11


Iris Coleman
Nov 22, 2025 17:59

INJ price prediction shows recovery to $6.33 within one week, followed by potential decline to $5.17 by December 21. Mixed analyst forecasts reflect current market uncertainty.

INJ Price Prediction Summary

• INJ short-term target (1 week): $6.33 (+16.4%)
• Injective medium-term forecast (1 month): $5.17-$7.50 range
• Key level to break for bullish continuation: $6.74 (20-day SMA)
• Critical support if bearish: $5.19 (immediate support)

Recent Injective Price Predictions from Analysts

The latest INJ price prediction landscape reveals a divided analyst community. Blockchain.News maintains an optimistic stance with their Injective forecast targeting $6.33 in the short term, despite the recent 12.88% decline. Their medium-term projection extends to $7.50-$9.17, banking on the upcoming Altria upgrade as a catalyst.

However, contrarian views emerge from CoinCheckup’s technical analysis, which suggests a bearish INJ price target of $5.17 by December 21, 2025. This creates an interesting dichotomy where short-term optimism meets medium-term pessimism. CoinMarketCap’s $9.17 prediction relies heavily on the Altria Mainnet Upgrade and potential ETF approvals, while Coinbase’s conservative long-term forecast of $7.14 by 2030 reflects a modest 5% annual growth expectation.

The consensus reveals medium confidence levels across most predictions, indicating uncertainty in the current market environment for Injective.

INJ Technical Analysis: Setting Up for Short-Term Recovery

Current technical indicators paint a mixed but potentially recovering picture for our INJ price prediction. With INJ trading at $5.44, the token sits precariously close to its 52-week low of $5.44, suggesting we may have found a temporary floor.

The RSI reading of 31.18 indicates oversold conditions without reaching extreme levels, providing room for a technical bounce. The MACD histogram at -0.0621 shows bearish momentum is weakening, though not yet reversed. Most compelling is INJ’s position within the Bollinger Bands at 0.0347, placing it near the lower band support at $5.34 – a classic setup for mean reversion toward the middle band at $6.74.

Volume analysis shows $7.25 million in 24-hour trading, which is moderate but sufficient to support a recovery move. The daily ATR of $0.82 suggests we could see significant price swings in either direction, supporting both the bullish $6.33 target and bearish $5.17 scenario.

Injective Price Targets: Bull and Bear Scenarios

Bullish Case for INJ

The primary bullish INJ price target of $6.33 aligns perfectly with technical resistance levels between the current price and the 7-day SMA at $6.10. Breaking above $6.33 would likely trigger momentum toward the 20-day SMA at $6.74, which serves as the critical level for sustained upward movement in our Injective forecast.

If bulls can reclaim the $6.74 level, the next logical target becomes $7.50, representing the middle ground of analyst predictions. The ultimate bullish scenario sees INJ reaching $9.17, contingent on successful implementation of the Altria upgrade and sustained buying pressure above all major moving averages.

Bearish Risk for Injective

The bearish case for our INJ price prediction centers on the failure to hold immediate support at $5.19. A break below this level would likely accelerate selling toward the CoinCheckup target of $5.17, representing a confluence of technical support levels.

The concerning aspect of current Injective technical analysis is the distance from major moving averages – INJ trades 66.44% below its 52-week high and significantly below the 50-day SMA at $8.31. This suggests any recovery attempts may face strong resistance at higher levels.

Should You Buy INJ Now? Entry Strategy

Based on our comprehensive INJ price prediction analysis, the current risk-reward setup favors a tactical approach. For those wondering whether to buy or sell INJ, consider these specific entry strategies:

Conservative Entry: Wait for a break above $5.66 (today’s high) with a stop-loss at $5.19. This approach targets the $6.33 level with a favorable 2:1 risk-reward ratio.

Aggressive Entry: Current levels around $5.44 offer proximity to strong support, but require a tight stop-loss below $5.19 to manage downside risk to the $5.17 target.

Position sizing should remain conservative given the mixed analyst sentiment and the proximity to 52-week lows. The technical setup suggests INJ could move decisively in either direction within the next two weeks.

INJ Price Prediction Conclusion

Our Injective forecast anticipates a near-term recovery to $6.33 within one week, supported by oversold technical conditions and analyst optimism surrounding the Altria upgrade. However, the medium-term outlook remains cautious, with a potential decline to $5.17 by December 21 if broader market conditions deteriorate.

Confidence Level: Medium for the $6.33 target, Medium-Low for the $5.17 bearish scenario.

Key indicators to monitor include the RSI breaking above 35 for bullish confirmation and MACD histogram turning positive. Failure to hold $5.19 support would validate the bearish $5.17 INJ price target. The timeline for this prediction spans the next 4-6 weeks, with the initial recovery phase expected within 7-10 days.

The Altria upgrade remains the wildcard that could invalidate bearish scenarios and propel INJ toward the higher analyst targets of $7.50-$9.17.

Image source: Shutterstock

Source: https://blockchain.news/news/20251122-price-prediction-inj-technical-recovery-to-633-before-december

Market Opportunity
Injective Logo
Injective Price(INJ)
$4.85
$4.85$4.85
-2.61%
USD
Injective (INJ) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise

China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise

The post China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise appeared on BitcoinEthereumNews.com. China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise China’s internet regulator has ordered the country’s biggest technology firms, including Alibaba and ByteDance, to stop purchasing Nvidia’s RTX Pro 6000D GPUs. According to the Financial Times, the move shuts down the last major channel for mass supplies of American chips to the Chinese market. Why Beijing Halted Nvidia Purchases Chinese companies had planned to buy tens of thousands of RTX Pro 6000D accelerators and had already begun testing them in servers. But regulators intervened, halting the purchases and signaling stricter controls than earlier measures placed on Nvidia’s H20 chip. Image: Nvidia An audit compared Huawei and Cambricon processors, along with chips developed by Alibaba and Baidu, against Nvidia’s export-approved products. Regulators concluded that Chinese chips had reached performance levels comparable to the restricted U.S. models. This assessment pushed authorities to advise firms to rely more heavily on domestic processors, further tightening Nvidia’s already limited position in China. China’s Drive Toward Tech Independence The decision highlights Beijing’s focus on import substitution — developing self-sufficient chip production to reduce reliance on U.S. supplies. “The signal is now clear: all attention is focused on building a domestic ecosystem,” said a representative of a leading Chinese tech company. Nvidia had unveiled the RTX Pro 6000D in July 2025 during CEO Jensen Huang’s visit to Beijing, in an attempt to keep a foothold in China after Washington restricted exports of its most advanced chips. But momentum is shifting. Industry sources told the Financial Times that Chinese manufacturers plan to triple AI chip production next year to meet growing demand. They believe “domestic supply will now be sufficient without Nvidia.” What It Means for the Future With Huawei, Cambricon, Alibaba, and Baidu stepping up, China is positioning itself for long-term technological independence. Nvidia, meanwhile, faces…
Share
BitcoinEthereumNews2025/09/18 01:37
The Truth Machine: Why SMX Is Becoming the Most Watched Microcap of 2025

The Truth Machine: Why SMX Is Becoming the Most Watched Microcap of 2025

Every industry eventually hits the moment where the narrative collapses under its own weight. Plastic recycling just hit that wall. Too many promises, not enough
Share
Techbullion2025/12/16 03:39
XRP crypto price Analysis: 1D Bearish, Exhaustion Rising

XRP crypto price Analysis: 1D Bearish, Exhaustion Rising

The post XRP crypto price Analysis: 1D Bearish, Exhaustion Rising appeared on BitcoinEthereumNews.com. The market is grinding lower under seller control, and even
Share
BitcoinEthereumNews2025/12/16 03:40